bladder transitional cell carcinoma Search Results


human embryonic kidney (hek) 293 t cells  (Pro-cell Co Ltd)
90
Pro-cell Co Ltd human embryonic kidney (hek) 293 t cells
Human Embryonic Kidney (Hek) 293 T Cells, supplied by Pro-cell Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human embryonic kidney (hek) 293 t cells/product/Pro-cell Co Ltd
Average 90 stars, based on 1 article reviews
human embryonic kidney (hek) 293 t cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human bladder papillary transitional cell carcinoma tsgh 8301 cells  (BioResource International Inc)
90
BioResource International Inc human bladder papillary transitional cell carcinoma tsgh 8301 cells
Human Bladder Papillary Transitional Cell Carcinoma Tsgh 8301 Cells, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human bladder papillary transitional cell carcinoma tsgh 8301 cells/product/BioResource International Inc
Average 90 stars, based on 1 article reviews
human bladder papillary transitional cell carcinoma tsgh 8301 cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
bladder transitional cell carcinoma cell lines j82  (Shanghai Yuanye Biochemicals)
90
Shanghai Yuanye Biochemicals bladder transitional cell carcinoma cell lines j82
Knockdown of ARHGAP5-, ARHGAP17-, and ARHGAP24-suppressed BC cell proliferation in vivo and in vitro . (A) System analysis of expression of ARHGAP family gene in BCa cancer cell lines in the CCLE database. (B) ARHGAP5, ARHGAP17, and ARHGAP24 expression in seven pairs of low-grade BCa and seven pairs of high-grade BCa; GAPDH serves as a loading control. (C) ARHGAP5, ARHGAP17, and ARHGAP24 expression in four bladder <t>transitional</t> cell carcinoma cell lines <t>(RT4,</t> UM-UC-3, <t>T24,</t> and 5637) compared with immortalized epithelium cell line (SV-HUC-1). (D,E) Cloning formation of T24, UMUC-3, and ARHGAP5, ARHGAP17, and ARHGAP24 knocking down T24, UMUC-3 (*** p < 0.001 versus shNC). (F,G) 5-Ethynyl-2′-deoxyuridine (EdU) assay of T24 and shARHGAP5-, ARHGAP17-, and ARHGAP24-transfected T24 (*** p < 0.001 versus shNC). (H) Tumor growth size of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 21 days after tumor implantation. (I) Tumor growth curve of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 in 21 days of tumor implantation. (J) Average weights of tumors from shNC and shARHGAP5, ARHGAP17, and ARHGAP24 are shown in the histogram. Error bars indicate SD.
Bladder Transitional Cell Carcinoma Cell Lines J82, supplied by Shanghai Yuanye Biochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bladder transitional cell carcinoma cell lines j82/product/Shanghai Yuanye Biochemicals
Average 90 stars, based on 1 article reviews
bladder transitional cell carcinoma cell lines j82 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
superficial transitional cell carcinoma of the urinary bladder  (Amira Pharmaceuticals)
90
Amira Pharmaceuticals superficial transitional cell carcinoma of the urinary bladder
Knockdown of ARHGAP5-, ARHGAP17-, and ARHGAP24-suppressed BC cell proliferation in vivo and in vitro . (A) System analysis of expression of ARHGAP family gene in BCa cancer cell lines in the CCLE database. (B) ARHGAP5, ARHGAP17, and ARHGAP24 expression in seven pairs of low-grade BCa and seven pairs of high-grade BCa; GAPDH serves as a loading control. (C) ARHGAP5, ARHGAP17, and ARHGAP24 expression in four bladder <t>transitional</t> cell carcinoma cell lines <t>(RT4,</t> UM-UC-3, <t>T24,</t> and 5637) compared with immortalized epithelium cell line (SV-HUC-1). (D,E) Cloning formation of T24, UMUC-3, and ARHGAP5, ARHGAP17, and ARHGAP24 knocking down T24, UMUC-3 (*** p < 0.001 versus shNC). (F,G) 5-Ethynyl-2′-deoxyuridine (EdU) assay of T24 and shARHGAP5-, ARHGAP17-, and ARHGAP24-transfected T24 (*** p < 0.001 versus shNC). (H) Tumor growth size of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 21 days after tumor implantation. (I) Tumor growth curve of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 in 21 days of tumor implantation. (J) Average weights of tumors from shNC and shARHGAP5, ARHGAP17, and ARHGAP24 are shown in the histogram. Error bars indicate SD.
Superficial Transitional Cell Carcinoma Of The Urinary Bladder, supplied by Amira Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/superficial transitional cell carcinoma of the urinary bladder/product/Amira Pharmaceuticals
Average 90 stars, based on 1 article reviews
superficial transitional cell carcinoma of the urinary bladder - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
rt4 t24 bladder transitional cell carcinoma cell lines  (Procell Inc)
90
Procell Inc rt4 t24 bladder transitional cell carcinoma cell lines
Knockdown of ARHGAP5-, ARHGAP17-, and ARHGAP24-suppressed BC cell proliferation in vivo and in vitro . (A) System analysis of expression of ARHGAP family gene in BCa cancer cell lines in the CCLE database. (B) ARHGAP5, ARHGAP17, and ARHGAP24 expression in seven pairs of low-grade BCa and seven pairs of high-grade BCa; GAPDH serves as a loading control. (C) ARHGAP5, ARHGAP17, and ARHGAP24 expression in four bladder <t>transitional</t> cell carcinoma cell lines <t>(RT4,</t> UM-UC-3, <t>T24,</t> and 5637) compared with immortalized epithelium cell line (SV-HUC-1). (D,E) Cloning formation of T24, UMUC-3, and ARHGAP5, ARHGAP17, and ARHGAP24 knocking down T24, UMUC-3 (*** p < 0.001 versus shNC). (F,G) 5-Ethynyl-2′-deoxyuridine (EdU) assay of T24 and shARHGAP5-, ARHGAP17-, and ARHGAP24-transfected T24 (*** p < 0.001 versus shNC). (H) Tumor growth size of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 21 days after tumor implantation. (I) Tumor growth curve of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 in 21 days of tumor implantation. (J) Average weights of tumors from shNC and shARHGAP5, ARHGAP17, and ARHGAP24 are shown in the histogram. Error bars indicate SD.
Rt4 T24 Bladder Transitional Cell Carcinoma Cell Lines, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt4 t24 bladder transitional cell carcinoma cell lines/product/Procell Inc
Average 90 stars, based on 1 article reviews
rt4 t24 bladder transitional cell carcinoma cell lines - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
bladder transitional cell carcinoma cell lines  (Shanghai Yuanye Biochemicals)
90
Shanghai Yuanye Biochemicals bladder transitional cell carcinoma cell lines
Knockdown of ARHGAP5-, ARHGAP17-, and ARHGAP24-suppressed BC cell proliferation in vivo and in vitro . (A) System analysis of expression of ARHGAP family gene in BCa cancer cell lines in the CCLE database. (B) ARHGAP5, ARHGAP17, and ARHGAP24 expression in seven pairs of low-grade BCa and seven pairs of high-grade BCa; GAPDH serves as a loading control. (C) ARHGAP5, ARHGAP17, and ARHGAP24 expression in four bladder <t>transitional</t> cell carcinoma cell lines <t>(RT4,</t> UM-UC-3, <t>T24,</t> and 5637) compared with immortalized epithelium cell line (SV-HUC-1). (D,E) Cloning formation of T24, UMUC-3, and ARHGAP5, ARHGAP17, and ARHGAP24 knocking down T24, UMUC-3 (*** p < 0.001 versus shNC). (F,G) 5-Ethynyl-2′-deoxyuridine (EdU) assay of T24 and shARHGAP5-, ARHGAP17-, and ARHGAP24-transfected T24 (*** p < 0.001 versus shNC). (H) Tumor growth size of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 21 days after tumor implantation. (I) Tumor growth curve of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 in 21 days of tumor implantation. (J) Average weights of tumors from shNC and shARHGAP5, ARHGAP17, and ARHGAP24 are shown in the histogram. Error bars indicate SD.
Bladder Transitional Cell Carcinoma Cell Lines, supplied by Shanghai Yuanye Biochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bladder transitional cell carcinoma cell lines/product/Shanghai Yuanye Biochemicals
Average 90 stars, based on 1 article reviews
bladder transitional cell carcinoma cell lines - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human urinary bladder transitional cell carcinoma (tccsup) cells  (Procell Inc)
90
Procell Inc human urinary bladder transitional cell carcinoma (tccsup) cells
Knockdown of ARHGAP5-, ARHGAP17-, and ARHGAP24-suppressed BC cell proliferation in vivo and in vitro . (A) System analysis of expression of ARHGAP family gene in BCa cancer cell lines in the CCLE database. (B) ARHGAP5, ARHGAP17, and ARHGAP24 expression in seven pairs of low-grade BCa and seven pairs of high-grade BCa; GAPDH serves as a loading control. (C) ARHGAP5, ARHGAP17, and ARHGAP24 expression in four bladder <t>transitional</t> cell carcinoma cell lines <t>(RT4,</t> UM-UC-3, <t>T24,</t> and 5637) compared with immortalized epithelium cell line (SV-HUC-1). (D,E) Cloning formation of T24, UMUC-3, and ARHGAP5, ARHGAP17, and ARHGAP24 knocking down T24, UMUC-3 (*** p < 0.001 versus shNC). (F,G) 5-Ethynyl-2′-deoxyuridine (EdU) assay of T24 and shARHGAP5-, ARHGAP17-, and ARHGAP24-transfected T24 (*** p < 0.001 versus shNC). (H) Tumor growth size of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 21 days after tumor implantation. (I) Tumor growth curve of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 in 21 days of tumor implantation. (J) Average weights of tumors from shNC and shARHGAP5, ARHGAP17, and ARHGAP24 are shown in the histogram. Error bars indicate SD.
Human Urinary Bladder Transitional Cell Carcinoma (Tccsup) Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human urinary bladder transitional cell carcinoma (tccsup) cells/product/Procell Inc
Average 90 stars, based on 1 article reviews
human urinary bladder transitional cell carcinoma (tccsup) cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
transitional cell carcinoma of the bladder  (Arisan Inc)
90
Arisan Inc transitional cell carcinoma of the bladder
Knockdown of ARHGAP5-, ARHGAP17-, and ARHGAP24-suppressed BC cell proliferation in vivo and in vitro . (A) System analysis of expression of ARHGAP family gene in BCa cancer cell lines in the CCLE database. (B) ARHGAP5, ARHGAP17, and ARHGAP24 expression in seven pairs of low-grade BCa and seven pairs of high-grade BCa; GAPDH serves as a loading control. (C) ARHGAP5, ARHGAP17, and ARHGAP24 expression in four bladder <t>transitional</t> cell carcinoma cell lines <t>(RT4,</t> UM-UC-3, <t>T24,</t> and 5637) compared with immortalized epithelium cell line (SV-HUC-1). (D,E) Cloning formation of T24, UMUC-3, and ARHGAP5, ARHGAP17, and ARHGAP24 knocking down T24, UMUC-3 (*** p < 0.001 versus shNC). (F,G) 5-Ethynyl-2′-deoxyuridine (EdU) assay of T24 and shARHGAP5-, ARHGAP17-, and ARHGAP24-transfected T24 (*** p < 0.001 versus shNC). (H) Tumor growth size of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 21 days after tumor implantation. (I) Tumor growth curve of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 in 21 days of tumor implantation. (J) Average weights of tumors from shNC and shARHGAP5, ARHGAP17, and ARHGAP24 are shown in the histogram. Error bars indicate SD.
Transitional Cell Carcinoma Of The Bladder, supplied by Arisan Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transitional cell carcinoma of the bladder/product/Arisan Inc
Average 90 stars, based on 1 article reviews
transitional cell carcinoma of the bladder - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
um-uc-9 (human transitional cell carcinoma of the bladder) cell line  (CancerTools Org)
N/A
UM-UC-9 (Human transitional cell carcinoma of the bladder) cell line
   Buy from Supplier
um-uc-6 (human bladder transitional cell carcinoma) cell line  (CancerTools Org)
N/A
UM-UC-6 was obtained by transurethral resection of a bladder transitional cell carcinoma found in a male patient. UM-UC-6 was found to produce tumours in athymic nude mice.
   Buy from Supplier
bladder tissue slides (transitional cell carcinoma)- paraffin  (Novus Biologicals)
N/A
Bladder Tissue Slides (Transitional Cell Carcinoma)- Paraffin
   Buy from Supplier

Image Search Results


Knockdown of ARHGAP5-, ARHGAP17-, and ARHGAP24-suppressed BC cell proliferation in vivo and in vitro . (A) System analysis of expression of ARHGAP family gene in BCa cancer cell lines in the CCLE database. (B) ARHGAP5, ARHGAP17, and ARHGAP24 expression in seven pairs of low-grade BCa and seven pairs of high-grade BCa; GAPDH serves as a loading control. (C) ARHGAP5, ARHGAP17, and ARHGAP24 expression in four bladder transitional cell carcinoma cell lines (RT4, UM-UC-3, T24, and 5637) compared with immortalized epithelium cell line (SV-HUC-1). (D,E) Cloning formation of T24, UMUC-3, and ARHGAP5, ARHGAP17, and ARHGAP24 knocking down T24, UMUC-3 (*** p < 0.001 versus shNC). (F,G) 5-Ethynyl-2′-deoxyuridine (EdU) assay of T24 and shARHGAP5-, ARHGAP17-, and ARHGAP24-transfected T24 (*** p < 0.001 versus shNC). (H) Tumor growth size of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 21 days after tumor implantation. (I) Tumor growth curve of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 in 21 days of tumor implantation. (J) Average weights of tumors from shNC and shARHGAP5, ARHGAP17, and ARHGAP24 are shown in the histogram. Error bars indicate SD.

Journal: Frontiers in Cell and Developmental Biology

Article Title: Transcriptomic Analysis Identified ARHGAP Family as a Novel Biomarker Associated With Tumor-Promoting Immune Infiltration and Nanomechanical Characteristics in Bladder Cancer

doi: 10.3389/fcell.2021.657219

Figure Lengend Snippet: Knockdown of ARHGAP5-, ARHGAP17-, and ARHGAP24-suppressed BC cell proliferation in vivo and in vitro . (A) System analysis of expression of ARHGAP family gene in BCa cancer cell lines in the CCLE database. (B) ARHGAP5, ARHGAP17, and ARHGAP24 expression in seven pairs of low-grade BCa and seven pairs of high-grade BCa; GAPDH serves as a loading control. (C) ARHGAP5, ARHGAP17, and ARHGAP24 expression in four bladder transitional cell carcinoma cell lines (RT4, UM-UC-3, T24, and 5637) compared with immortalized epithelium cell line (SV-HUC-1). (D,E) Cloning formation of T24, UMUC-3, and ARHGAP5, ARHGAP17, and ARHGAP24 knocking down T24, UMUC-3 (*** p < 0.001 versus shNC). (F,G) 5-Ethynyl-2′-deoxyuridine (EdU) assay of T24 and shARHGAP5-, ARHGAP17-, and ARHGAP24-transfected T24 (*** p < 0.001 versus shNC). (H) Tumor growth size of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 21 days after tumor implantation. (I) Tumor growth curve of subcutaneous T24 tumors transfected with shNC or shARHGAP5, ARHGAP17, and ARHGAP24 in 21 days of tumor implantation. (J) Average weights of tumors from shNC and shARHGAP5, ARHGAP17, and ARHGAP24 are shown in the histogram. Error bars indicate SD.

Article Snippet: Bladder transitional cell carcinoma cell lines (RT4, UM-UC-3, T24, 5,637, and J82), immortalized uroepithelium cell line (SV-HUC-1), and human embryonic kidney cells (HEK-293) were received from Shanghai Yuanye Bio-Technology Co. (Shanghai, China).

Techniques: Knockdown, In Vivo, In Vitro, Expressing, Control, Cloning, EdU Assay, Transfection, Tumor Implantation